Home › Funds › VILLERE ST DENIS J & CO LLC › LGND

VILLERE ST DENIS J & CO LLC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

VILLERE ST DENIS J & CO LLC reported holding 93,325 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$29.2M, representing 3.76% of its reported portfolio and ranking #6 among its reported holdings. VILLERE ST DENIS J & CO LLC has disclosed LGND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)93.33K sh
Reported value held$29.15M
Portfolio Weight3.76%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VILLERE ST DENIS J & CO LLC's LGND position evolved

VILLERE ST DENIS J & CO LLC first disclosed a stake in LGND in Q3 2023 at 438,161 shares (US$26.3M). The position peaked in Q3 2025 at 279,950 shares, worth US$49.6M. Across 13 filings, VILLERE ST DENIS J & CO LLC increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 93,325 shares valued at US$29.2M — a reduction of -62,181 shares quarter over quarter.. Notable position changes include a 40% trim in Q4 2024 (shares fell 2% over the following quarter), a 28% trim in Q4 2025 (shares rose 6% over the following quarter), a 40% trim in Q3 2026 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 438.16K $26.25M New
Q4 2023 428.05K $30.57M Reduce
Q1 2024 490.75K $35.87M Add
Q2 2024 483.91K $40.77M Reduce
Q3 2024 474.86K $47.53M Reduce
Q4 2024 287.04K $30.76M Reduce
Q1 2025 288.83K $30.37M Add
Q2 2025 287.12K $32.64M Reduce
Q3 2025 279.95K $49.59M Reduce
Q4 2025 202.45K $38.28M Reduce
Q1 2026 188.87K $37.71M Reduce
Q2 2026 155.51K $49.15M Reduce
Q3 2026 93.33K $29.15M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has VILLERE ST DENIS J & CO LLC held LGND?

VILLERE ST DENIS J & CO LLC has disclosed LGND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VILLERE ST DENIS J & CO LLC's current position in LGND?

As of Q3 2026, VILLERE ST DENIS J & CO LLC holds 93.33K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $29.15M, representing 3.76% of its reported portfolio and ranking #6.

Has VILLERE ST DENIS J & CO LLC been buying or selling LGND?

In the latest 13F filing (Q3 2026), VILLERE ST DENIS J & CO LLC reduced its position in LGND. The position peaked in Q3 2025 at 279.95K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.